UTI Core Equity Fund Direct Growth

Fund Overview

Fund Size

₹3,441 Cr

Expense Ratio

1.19%

ISIN

INF789F01UG3

Minimum SIP

₹1,000

Exit Load

1.00%

Inception Date

01 Jan 2013

About this fund

UTI Core Equity Fund Direct Growth is a Large & Mid-Cap mutual fund schemes offered by UTI Mutual Fund. This fund has been in existence for 11 years, 6 months and 25 days, having been launched on 01-Jan-13.
As of 25-Jul-24, it has a Net Asset Value (NAV) of ₹186.08, Assets Under Management (AUM) of 3440.75 Crores, and an expense ratio of 1.19%.

UTI Core Equity Fund Direct Growth has given a CAGR return of 16.62% since inception.
The fund's asset allocation comprises around 94.31% in equities, 0.11% in debts, and 5.58% in cash & cash equivalents.
You can start investing in UTI Core Equity Fund Direct Growth with a SIP of ₹1000 or a Lumpsum investment of ₹5000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+50.16%

+42.91% (Cat Avg.)

3 Years

+24.34%

+21.68% (Cat Avg.)

5 Years

+24.93%

+22.99% (Cat Avg.)

10 Years

+16.18%

+16.47% (Cat Avg.)

Since Inception

+16.62%

— (Cat Avg.)

Portfolio Summaryas of 30th June 2024

Equity	₹3,244.89 Cr	94.31%
Debt	₹3.84 Cr	0.11%
Others	₹192.02 Cr	5.58%

Top Holdings

All Holdings

Equity

Debt & Others

Name	Type	Amount	Holdings
HDFC Bank Ltd	Equity	₹282.62 Cr	8.21%
Net Current Assets	Cash	₹191.13 Cr	5.55%
ICICI Bank Ltd	Equity	₹172.02 Cr	5.00%
ITC Ltd	Equity	₹120.63 Cr	3.51%
Oracle Financial Services Software Ltd	Equity	₹98.15 Cr	2.85%
Reliance Industries Ltd	Equity	₹95.14 Cr	2.77%
Infosys Ltd	Equity	₹78.94 Cr	2.29%
Axis Bank Ltd	Equity	₹75.94 Cr	2.21%
The Federal Bank Ltd	Equity	₹74.89 Cr	2.18%
Max Financial Services Ltd	Equity	₹74.01 Cr	2.15%
Aurobindo Pharma Ltd	Equity	₹71.12 Cr	2.07%
Dalmia Bharat Ltd	Equity	₹67.62 Cr	1.97%
Aditya Birla Capital Ltd	Equity	₹66.17 Cr	1.92%
Indus Towers Ltd Ordinary Shares	Equity	₹62.26 Cr	1.81%
Raymond Ltd	Equity	₹59.21 Cr	1.72%
Mahindra & Mahindra Ltd	Equity	₹58.41 Cr	1.70%
Bharti Airtel Ltd	Equity	₹58.12 Cr	1.69%
Kotak Mahindra Bank Ltd	Equity	₹57.6 Cr	1.67%
Apollo Tyres Ltd	Equity	₹57.18 Cr	1.66%
Coromandel International Ltd	Equity	₹56.8 Cr	1.65%
Indian Bank	Equity	₹55.84 Cr	1.62%
Phoenix Mills Ltd	Equity	₹55.47 Cr	1.61%
HCL Technologies Ltd	Equity	₹55.38 Cr	1.61%
Emami Ltd	Equity	₹54.48 Cr	1.58%
InterGlobe Aviation Ltd	Equity	₹53.54 Cr	1.56%
Nippon Life India Asset Management Ltd Ordinary Shares	Equity	₹52.97 Cr	1.54%
Indraprastha Gas Ltd	Equity	₹49.09 Cr	1.43%
Star Health and Allied Insurance Co Ltd	Equity	₹47.66 Cr	1.39%
Great Eastern Shipping Co Ltd	Equity	₹47.11 Cr	1.37%
Oil India Ltd	Equity	₹45.45 Cr	1.32%
Larsen & Toubro Ltd	Equity	₹44.24 Cr	1.29%
Jubilant Foodworks Ltd	Equity	₹44.13 Cr	1.28%
Tata Motors Ltd Class A	Equity	₹43.82 Cr	1.27%
Vedanta Ltd	Equity	₹43.72 Cr	1.27%
IndusInd Bank Ltd	Equity	₹42.77 Cr	1.24%
Mphasis Ltd	Equity	₹42.76 Cr	1.24%
Crompton Greaves Consumer Electricals Ltd	Equity	₹42.56 Cr	1.24%
Glenmark Pharmaceuticals Ltd	Equity	₹42.07 Cr	1.22%
Power Grid Corp Of India Ltd	Equity	₹41.48 Cr	1.21%
GAIL (India) Ltd	Equity	₹40.59 Cr	1.18%
Wipro Ltd	Equity	₹40.58 Cr	1.18%
Fortis Healthcare Ltd	Equity	₹40.13 Cr	1.17%
HDFC Life Insurance Company Limited	Equity	₹39.97 Cr	1.16%
Jindal Stainless Ltd	Equity	₹39.17 Cr	1.14%
Gland Pharma Ltd	Equity	₹37.37 Cr	1.09%
Shriram Finance Ltd	Equity	₹36.87 Cr	1.07%
Bajaj Auto Ltd	Equity	₹34.16 Cr	0.99%
JK Paper Ltd	Equity	₹31.26 Cr	0.91%
Ajanta Pharma Ltd	Equity	₹30.66 Cr	0.89%
Hindalco Industries Ltd	Equity	₹29.39 Cr	0.85%
Mahindra Holidays & Resorts India Ltd	Equity	₹29.09 Cr	0.85%
GHCL Ltd	Equity	₹27.61 Cr	0.80%
Marksans Pharma Ltd	Equity	₹27.04 Cr	0.79%
Sundaram Finance Ltd	Equity	₹26.32 Cr	0.76%
G R Infraprojects Ltd	Equity	₹26.14 Cr	0.76%
Zydus Lifesciences Ltd	Equity	₹22.81 Cr	0.66%
Indo Count Industries Ltd	Equity	₹19.75 Cr	0.57%
NIIT Learning Systems Ltd	Equity	₹17.99 Cr	0.52%
Caplin Point Laboratories Ltd	Equity	₹17.6 Cr	0.51%
Bharti Hexacom Ltd	Equity	₹16.33 Cr	0.47%
Bharti Airtel Ltd (Partly Paid Rs.1.25)	Equity	₹15.86 Cr	0.46%
Dr Reddy's Laboratories Ltd	Equity	₹6.84 Cr	0.20%
India (Republic of)	Bond - Short-term Government Bills	₹3.84 Cr	0.11%
Clearing Corporation Of India Ltd. Std - Margin	Cash - Repurchase Agreement	₹0.89 Cr	0.03%

Allocation By Market Cap (Equity)

Allocation By Credit Quality (Debt)

AAA

Other Allocation

Equity Sector

Debt & Others

Sector	Amount	Holdings
Financial Services	₹1,105.63 Cr	32.13%
Consumer Cyclical	₹388.3 Cr	11.29%
Technology	₹315.81 Cr	9.18%
Healthcare	₹295.64 Cr	8.59%
Basic Materials	₹295.57 Cr	8.59%
Consumer Defensive	₹193.11 Cr	5.61%
Industrials	₹171.03 Cr	4.97%
Communication Services	₹152.57 Cr	4.43%
Energy	₹140.59 Cr	4.09%
Utilities	₹131.16 Cr	3.81%
Real Estate	₹55.47 Cr	1.61%

Risk & Performance Ratios

Fund Managers

V Srivatsa

Since May 2017

Additional Scheme Detailsas of 30th June 2024

ISIN

INF789F01UG3

Expense Ratio

1.19%

Exit Load

1.00%

Fund Size

₹3,441 Cr

Age

01 Jan 2013

Lumpsum Minimum

₹5,000

Fund Status

Open Ended Investment Company

Benchmark

Nifty LargeMidcap 250 TR INR

Investment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Withdrawal within 1 year

Flat 15% tax on realised gains (STCG - short term capital gains)

Withdrawal after 1 year

10% tax on realised gains above Rs. 1 lakh per financial year (LTCG - long term capital gains)

Note: Mutual funds are subject to capital gains taxation with surcharge and cess, based on prevailing income tax rules and investor income. Taxation applies to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Large & Mid-Cap Funds

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Union Large & Midcap Fund Direct Growth Very High Risk	0.8%	1.0%	₹817.18 Cr	34.3%
Union Large & Midcap Fund Regular Growth Very High Risk	2.3%	1.0%	₹817.18 Cr	32.4%
HSBC Large & Mid Cap Fund Regular Growth Very High Risk	1.9%	1.0%	₹2768.75 Cr	47.1%
HSBC Large & Mid Cap Fund Direct Growth Very High Risk	0.9%	1.0%	₹2768.75 Cr	48.6%
Baroda BNP Paribas Large & Mid Cap Fund Regular Growth Very High Risk	2.1%	1.0%	₹1297.51 Cr	43.4%
Baroda BNP Paribas Large & Mid Cap Fund Direct Growth Very High Risk	0.9%	1.0%	₹1297.51 Cr	45.3%
Tata Large & Mid Cap Fund Regular Growth Very High Risk	1.8%	1.0%	₹7967.53 Cr	30.5%
Navi Large & Midcap Fund Regular Growth Very High Risk	2.3%	0.0%	₹311.66 Cr	25.7%
Navi Large & Midcap Fund Direct Growth Very High Risk	0.3%	0.0%	₹311.66 Cr	28.1%
UTI Core Equity Fund Regular Growth Very High Risk	2.0%	1.0%	₹3440.75 Cr	48.9%

About the AMC

UTI Mutual Fund

+91-22-6678 6666

https://www.utimf.com/

Total AUM

₹2,92,994 Cr

Address

UTI Towers, Gn Block, Mumbai, 400 051

Other Funds by UTI Mutual Fund

Fund name	Expense Ratio	Exit Load	Fund size	1Y
UTI Innovation Fund Direct Growth Very High Risk	0.9%	1.0%	₹699.04 Cr	-
UTI Fixed Income Interval Fund Annual Plan I Direct Growth Low Risk	-	0.0%	₹20.40 Cr	6.9%
UTI Fixed Term Income Fund - Series XXXV-I (1260 Days) Direct Growth Low to Moderate Risk	-	0.0%	-	7.6%
UTI Fixed Term Income Fund - Series XXXV-III (1176 Days) Direct Growth Low to Moderate Risk	-	0.0%	-	7.6%
UTI FIIF Ser 2 Qt Interval V Direct Growth Low Risk	-	1.0%	₹4.80 Cr	6.8%
UTI Fixed Income Interval Fund Quarterly I Direct Growth Low Risk	-	0.0%	₹10.46 Cr	7.1%
UTI Fixed Inc Intvl Series2 Qt Intvl VI Direct Growth Moderate Risk	-	1.0%	₹11.46 Cr	7.2%
UTI-Fixed Term Income Fund - Series XXX-VI (1107 days) Direct Growth Low to Moderate Risk	-	0.0%	-	10.0%
UTI-Fixed Term Income Fund - Series XXX - VII (1294 days) Direct Growth Low to Moderate Risk	-	0.0%	-	-
UTI Fixed Term Income Fund - Series XXXV-II (1223 Days) Direct Growth Moderate Risk	-	-	-	7.6%
UTI Fixed Income Interval Fund Annual Plan III Direct Growth Low to Moderate Risk	-	0.0%	₹13.38 Cr	6.9%
UTI Fixed Term Income Fund - Series XXXVI-I (1574 days) Direct Growth Low to Moderate Risk	-	0.0%	-	8.0%
UTI Floater Fund Direct Growth Low to Moderate Risk	0.3%	0.0%	₹1378.45 Cr	7.3%
UTI Nifty 500 Value 50 Index Fund Direct Growth Very High Risk	0.6%	0.0%	₹308.39 Cr	84.2%
UTI Banking & PSU Debt Fund Direct Growth Moderate Risk	0.2%	0.0%	₹839.11 Cr	7.3%
UTI Focused Equity Fund Direct Growth Very High Risk	0.6%	1.0%	₹2738.29 Cr	36.5%
UTI Silver ETF Fund of Fund Direct Growth Very High Risk	0.1%	1.0%	₹27.90 Cr	12.2%
UTI Nifty200 Momentum 30 Index Fund Direct Growth Very High Risk	0.5%	0.0%	₹6971.45 Cr	63.9%
UTI Overnight Fund Direct Growth Low Risk	0.1%	0.0%	₹3948.39 Cr	6.8%
UTI Corporate Bond Fund Direct Growth Moderate Risk	0.3%	0.0%	₹3796.48 Cr	7.5%
UTI Nifty Midcap 150 Quality 50 Index Fund Direct Growth Very High Risk	0.5%	0.0%	₹229.47 Cr	39.3%
UTI Arbitrage Fund Direct Growth Low Risk	0.4%	0.0%	₹5521.20 Cr	8.5%
UTI Small Cap Fund Direct Growth Very High Risk	0.4%	1.0%	₹4221.01 Cr	43.4%
UTI Ultra Short Term Fund Direct Growth Moderate Risk	0.4%	0.0%	₹2239.53 Cr	7.6%
UTI Credit Risk Fund Direct Growth Moderately High risk	0.9%	1.0%	₹386.27 Cr	7.5%
UTI Dividend Yield Fund Direct Growth Very High Risk	1.4%	1.0%	₹4071.32 Cr	50.9%
UTI Banking and Financial Services Fund Direct Growth Very High Risk	1.1%	1.0%	₹1140.83 Cr	20.6%
UTI Dynamic Bond Fund Direct Growth Moderate Risk	0.7%	0.0%	₹479.82 Cr	8.2%
UTI Hybrid Equity Fund Direct Growth Very High Risk	1.3%	1.0%	₹5851.61 Cr	33.8%
UTI Long Term Equity Fund Direct Growth Very High Risk	0.8%	0.0%	₹3918.51 Cr	34.5%
UTI Flexi Cap Fund Direct Growth Very High Risk	0.9%	1.0%	₹25696.23 Cr	23.2%
UTI Bond Fund Direct Growth Moderate Risk	1.2%	0.0%	₹301.30 Cr	7.2%
UTI Liquid Fund Cash Plan Direct Growth Moderate Risk	0.2%	0.0%	₹24127.08 Cr	7.4%
UTI Gilt Fund Direct Growth Moderate Risk	0.7%	0.0%	₹643.00 Cr	8.2%
UTI India Consumer Fund Direct Growth Very High Risk	1.5%	1.0%	₹660.51 Cr	38.6%
UTI Infrastructure Fund Direct Growth Very High Risk	1.8%	1.0%	₹2409.84 Cr	55.9%
UTI MNC Fund Direct Growth Very High Risk	1.1%	1.0%	₹3100.83 Cr	36.6%
UTI Master Share Unit Scheme Direct Growth Very High Risk	0.8%	1.0%	₹13182.87 Cr	29.1%
UTI Regular Savings Fund Direct Growth Moderately High risk	1.2%	1.0%	₹1617.22 Cr	15.6%
UTI Money Market Fund Direct Growth Moderate Risk	0.2%	0.0%	₹16266.52 Cr	7.6%
UTI Mid Cap Fund Direct Growth Very High Risk	0.8%	1.0%	₹11692.15 Cr	42.3%
UTI Value Opportunities Fund Direct Growth Very High Risk	1.1%	1.0%	₹9902.89 Cr	44.6%
UTI Healthcare Fund Direct Growth Very High Risk	1.3%	1.0%	₹985.80 Cr	48.3%
UTI Nifty 50 Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹18345.17 Cr	25.2%
UTI Transportation & Logistics Fund Direct Growth Very High Risk	0.8%	1.0%	₹3698.11 Cr	54.9%
UTI Short Term Income Fund Direct Growth Moderate Risk	0.4%	0.0%	₹2566.21 Cr	7.8%
UTI - Treasury Advantage Fund Direct Growth Moderate Risk	0.3%	0.0%	₹2428.81 Cr	7.3%
UTI Multi Asset Fund Direct Growth High Risk	1.1%	1.0%	₹2418.31 Cr	38.3%
UTI Core Equity Fund Direct Growth Very High Risk	1.2%	1.0%	₹3440.75 Cr	50.2%
UTI Medium Term Fund Direct Growth Moderate Risk	0.9%	1.0%	₹39.86 Cr	7.3%

Risk Level

Your principal amount will be at Very High Risk

Still got questions?
We're here to help.

What is the current NAV of UTI Core Equity Fund Direct Growth?

The NAV of UTI Core Equity Fund Direct Growth, as of 25-Jul-2024, is ₹186.08.

What are the returns of UTI Core Equity Fund Direct Growth?

The fund has generated 50.16% over the last 1 year and 24.34% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.

What is the portfolio composition of UTI Core Equity Fund Direct Growth?

The fund's allocation of assets is distributed as 94.31% in equities, 0.11% in bonds, and 5.58% in cash and cash equivalents.

Who manages the UTI Core Equity Fund Direct Growth?

The fund managers responsible for UTI Core Equity Fund Direct Growth are:-

V Srivatsa

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme-related documents carefully. The NAVs of the schemes may go up or down depending upon the factors and forces affecting the securities market including the fluctuations in the interest rates. The past performance of the mutual funds is not necessarily indicative of the future performance of the schemes. Investors are requested to review the prospectus carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.

;

©2021-2022 Dezerv. All Rights Reserved

Dezerv Investments Private Limited is a Portfolio Manager with SEBI Registration no. INP000007377 and an Investment Manager to Category - I AIF-VCF-Angel Fund with SEBI Registration no. IN/AIF1/22-23/1066.

Mutual Fund distribution services are offered through Dezerv Distribution Services Pvt Limited, a wholly owned subsidiary with AMFI Registration No.: ARN -248439. **Mutual fund investments are subject to market risks, read all scheme related documents carefully.** Terms and conditions of the website are applicable. Privacy policy of the website is applicable.